CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 25 enrolled
Drug / intervention
Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissueprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03996005
NCT03996005N/ACompleted
CompareCT.gov

Evaluation of an Alternative Treatment of Localized Prostate Cancer by Guided MRI Transurtral Ultrasound With 1-year Control of the Absence of Cancer

University Hospital, Strasbourg, France·interventional·Posted Jun 24, 2019·Updated Jan 8, 2026

In Brief

A clinical study evaluating Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissue for MRI Guided Transurethral Ultrasound Ablation and 2 related conditions. Completed, enrolled 25 participants across 1 site.

Detailed Summary

Primary purpose : Evaluation of the efficiency and safety of an alternative global prostate treatment in localized prostate cancer. Primary Objective: Absence of clinically significant cancer (CSC) on control biopsy at 1-year follow-up. Secondary Objectives: 1. Biochemical response 2. Presence of any CSC on biopsy at 1- and 2-year follow-up 3. Radical treatment free survival 4. Adverse events, clinical tolerance 5. Urinary continence 6. Erectile function 7. Quality of life

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMRI Guided Transurethral Ultrasound Ablation, Localized Prostate Cancer, Ablation Therapy
CountriesFrance
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJun 24, 2019
Enrollment StartSep 24, 2019
Primary CompletionJul 25, 2023
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 7.0 years ago

Interventions

Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissueprocedure

Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissue